Merck to Pay $830M to Settle Vioxx Suit

Drug Industry Daily
A A
Merck has agreed to pay $830 million to settle claims that it failed to inform investors of the heart risks related to its Vioxx pain medication, which is now discontinued.

To View This Article:

Login

Subscribe To Drug Industry Daily